Thu, September 23, 2021
Wed, September 22, 2021
Tue, September 21, 2021
Mon, September 20, 2021
Fri, September 17, 2021
Thu, September 16, 2021
Wed, September 15, 2021
Tue, September 14, 2021
Mon, September 13, 2021
Fri, September 10, 2021
Thu, September 9, 2021

Colin Bristow Maintained (BIIB) at Strong Buy with Decreased Target to $442 on, Sep 16th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-442-on-sep-16th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Colin Bristow of UBS, Maintained "Biogen Inc." (BIIB) at Strong Buy with Decreased Target from $475 to $442 on, Sep 16th, 2021.

Colin has made no other calls on BIIB in the last 4 months.



There are 16 other peers that have a rating on BIIB. Out of the 16 peers that are also analyzing BIIB, 6 agree with Colin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Salim Syed of "Mizuho" Maintained at Hold with Increased Target to $300 on, Monday, August 2nd, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $341 on, Friday, July 23rd, 2021
  • Terence Flynn of "Goldman Sachs" Maintained at Hold with Increased Target to $436 on, Monday, June 14th, 2021
  • Brian Skorney of "Baird" Upgraded from Sell to Hold and Increased Target to $382 on, Tuesday, June 8th, 2021
  • Carter Gould of "Barclays" Maintained at Hold with Increased Target to $395 on, Tuesday, June 8th, 2021
  • Mohit Bansal of "Citigroup" Upgraded from Strong Sell to Hold and Increased Target to $440 on, Tuesday, June 8th, 2021


These are the ratings of the 10 analyists that currently disagree with Colin


  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $423 on, Tuesday, July 27th, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $455 on, Friday, July 23rd, 2021
  • Christopher Raymond of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $450 on, Friday, June 18th, 2021
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $647 on, Monday, June 14th, 2021
  • Aaron Gal of "Bernstein" Upgraded from Hold to Buy and Held Target at $500 on, Friday, June 11th, 2021
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $475 on, Thursday, June 10th, 2021
  • Matt Phipps of "William Blair" Upgraded from Hold to Buy on, Tuesday, June 8th, 2021
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $452 on, Tuesday, June 8th, 2021
  • Michael Yee of "Jefferies" Maintained at Strong Buy with Increased Target to $500 on, Tuesday, June 8th, 2021
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $325 on, Tuesday, May 18th, 2021

Publication Contributing Sources